Patch-clamp recordings: Voltage step current

KK Kaivan Khavandi
RB Rachael A. Baylie
SS Sarah A. Sugden
MA Majid Ahmed
VC Viktoria Csato
PE Philip Eaton
DH David C. Hill-Eubanks
AB Adrian D. Bonev
MN Mark T. Nelson
AG Adam S. Greenstein
ask Ask a question
Favorite

For conventional whole-cell experiments, the pipette solution contained 10 mM HEPES, 110 mM K-aspartate, 1 mM MgCl2, 30 mM KCl, 10 mM NaCl, 5 mM EGTA and 2.5 mM CaCl2, with pH adjusted to 7.2 with KOH. Free Ca2+ was 200 nM, calculated using the online Ca-Mg-ATP-EGTA calculator V1.0 using constants from NIST database #46 V8 (http://maxchelator.stanford.edu/CaMgATPEGTA-NIST.htm). Outward currents were measured during 250-ms voltage steps from -40 mV to +50 mV in 10-mV increments, from a holding potential of -50 mV, in the presence or absence of the selective BK channel inhibitor, paxilline (1 μM). BK current amplitude was estimated from difference currents (±paxilline) calculated using Clampex 10.4. All recordings were performed at room temperature (~22°C). Corrections for liquid junction potentials were applied using the amplifier prior to recordings. For perforated-patch protocols with voltage-stepped current measurements, the pipette and bath solutions were the same as outlined above for the measurement of STOCs with nifedipine and ryanodine in the bath solution.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A